GlassScriptPhysician profile
Zaki G Ibrahim
NPI 1689612889
$18,640.58
in general payments reported to CMS, 2019-2025
17 companies · $722 in 2025
The $722 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,860 · 2020: $356 · 2021: $2,518 · 2022: $1,575 · 2023: $407 · 2024: $4,203 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923 · Travel and Lodging: $1,876 · Royalty Or License: $1,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.55 |
| Travel and Lodging | $1,875.77 |
| Royalty Or License | $1,533.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $10,425.30 | 2019-2022 | |
| Xtant Medical INC | $3,547.96 | 2023-2025 | |
| Globus Medical, INC. | $1,685.47 | 2019-2022 | |
| Biotronik Nro, INC. | $1,279.00 | 2024-2025 | Prospera |
| Medtronic USA, INC. | $409.63 | 2019-2020 | |
| Ziehm-Orthoscan, INC. | $302.10 | 2019 | |
| Stryker Corporation | $267.39 | 2021-2025 | Ivas, Omnicurve |
| Medtronic, INC. | $197.77 | 2021 | |
| Wardlow Enterprises | $143.41 | 2023 | |
| Providence Medical Technology, INC. | $134.54 | 2022 | |
| Prism Medical | $75.77 | 2025 | |
| Augmedics INC. | $70.02 | 2020 | |
| Spineology INC. | $32.00 | 2022 | |
| Centinel Spine, LLC | $24.78 | 2020 | |
| Heron Therapeutics, INC. | $17.04 | 2024 | Zynrelef |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $15.24 | 2025 | Zilretta, Iovera |
| Amgen INC. | $13.16 | 2024 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaki Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.